+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

The effect of tetrahydroaminoacridine (THA) on P300 in Alzheimer's disease

The effect of tetrahydroaminoacridine (THA) on P300 in Alzheimer's disease

Biological Psychiatry 30(9): 953-957

(PDF emailed within 0-6 h: $19.90)

Accession: 033785220

Download citation: RISBibTeXText

PMID: 1747439

DOI: 10.1016/0006-3223(91)90008-a

Related references

Tetrahydroaminoacridine improves the recency effect in Alzheimer's disease. Neuroscience 83(2): 471-479, 1998

Effect of tetrahydroaminoacridine on cognition function and behavior in alzheimer's disease. Canadian Medical Association Journal 144(1): 29-34, 1991

Anatomy of cholinesterase inhibition in Alzheimer's disease: effect of physostigmine and tetrahydroaminoacridine on plaques and tangles. Annals of Neurology 22(6): 683-691, 1987

Canadian collaborative study of tetrahydroaminoacridine (THA) and lecithin treatment of Alzheimer's disease: effect on mood. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 34(3): 165-170, 1989

Tacrine (tetrahydroaminoacridine; THA) and lecithin in senile dementia of the Alzheimer type: a multicentre trial. Groupe Fran├žais d'Etude de la Tetrahydroaminoacridine. Bmj 300(6723): 495-499, 1990

Tetrahydroaminoacridine and lecithin in the treatment of alzheimer's disease effect on cognition functioning in daily life behavioral disturbances and burden experienced by the carers. Journal of Neurology 238(1): 34-38, 1991

Tetrahydroaminoacridine and Alzheimer's disease. Lancet 1(8528): 322-322, 1987

Tetrahydroaminoacridine (THA) in Alzheimer's disease. Bmj 298(6677): 845-846, 1989

Tetrahydroaminoacridine in Alzheimer's disease. Bmj 298(6682): 1250-1251, 1989

Tetrahydroaminoacridine and lecithin for Alzheimer's disease. New England Journal of Medicine 323(13): 919-920, 1990

Physostigmine and tetrahydroaminoacridine treatment of Alzheimer's disease. Acta Neurologica Scandinavica 88(SUPPL. 149): 39-41, 1993

Tetrahydroaminoacridine: a promising 'therapy' for Alzheimer's disease?. Nederlands Tijdschrift Voor Geneeskunde 132(40): 1833-1835, 1988